BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31958486)

  • 1. Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinoma.
    Broutian TR; Jiang B; Li J; Akagi K; Gui S; Zhou Z; Xiao W; Symer DE; Gillison ML
    Cancer Lett; 2020 Apr; 476():23-33. PubMed ID: 31958486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines.
    Olthof NC; Huebbers CU; Kolligs J; Henfling M; Ramaekers FC; Cornet I; van Lent-Albrechts JA; Stegmann AP; Silling S; Wieland U; Carey TE; Walline HM; Gollin SM; Hoffmann TK; de Winter J; Kremer B; Klussmann JP; Speel EJ
    Int J Cancer; 2015 Mar; 136(5):E207-18. PubMed ID: 25082736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation.
    Liu C; Sadat SH; Ebisumoto K; Sakai A; Panuganti BA; Ren S; Goto Y; Haft S; Fukusumi T; Ando M; Saito Y; Guo T; Tamayo P; Yeerna H; Kim W; Hubbard J; Sharabi AB; Gutkind JS; Califano JA
    Clin Cancer Res; 2020 Jun; 26(11):2693-2703. PubMed ID: 31932491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma.
    Berggren KL; Restrepo Cruz S; Hixon MD; Cowan AT; Keysar SB; Craig S; James J; Barry M; Ozbun MA; Jimeno A; McCance DJ; Beswick EJ; Gan GN
    Oncogene; 2019 Nov; 38(48):7329-7341. PubMed ID: 31417185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Gene Expression Profiling of Tobacco-Associated HPV-Positive versus Negative Oral Squamous Carcinoma Cell Lines.
    Lepore S; Lettini G; Condelli V; Sisinni L; Piscazzi A; Simeon V; Zoppoli P; Pedicillo MC; Natalicchio MI; Pietrafesa M; Landriscina M
    Int J Med Sci; 2020; 17(1):112-124. PubMed ID: 31929745
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.
    Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E
    Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
    Du S; Liu K; Gao P; Li Z; Zheng J
    Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin alpha 6 as a stemness driver is a novel promising target for HPV (+) head and neck squamous cell carcinoma.
    An JS; Moon JH; Kim C; No JK; Eun YG; Chang Lim Y
    Exp Cell Res; 2021 Oct; 407(2):112815. PubMed ID: 34496296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.
    Hatano T; Sano D; Takahashi H; Hyakusoku H; Isono Y; Shimada S; Sawakuma K; Takada K; Oikawa R; Watanabe Y; Yamamoto H; Itoh F; Myers JN; Oridate N
    Int J Cancer; 2017 Apr; 140(7):1571-1580. PubMed ID: 28006857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumorigenic activation around HPV integrated sites in head and neck squamous cell carcinoma.
    Mima M; Okabe A; Hoshii T; Nakagawa T; Kurokawa T; Kondo S; Mizokami H; Fukuyo M; Fujiki R; Rahmutulla B; Yoshizaki T; Hanazawa T; Misawa K; Kaneda A
    Int J Cancer; 2023 May; 152(9):1847-1862. PubMed ID: 36650703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.
    Alsahafi EN; Thavaraj S; Sarvestani N; Novoplansky O; Elkabets M; Ayaz B; Tavassoli M; Legends MF
    Cancer Lett; 2021 Feb; 498():80-97. PubMed ID: 33137407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
    Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
    Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Glial cell derived neurotrophic factor in head and neck cancer.
    Cao H; He Q; Eyben RV; Bloomstein J; Nambiar DK; Viswanathan V; Aggarwal S; Kwok S; Liang R; Koong AJ; Lewis JS; Kong C; Xiao N; Le QT
    PLoS One; 2020; 15(2):e0229311. PubMed ID: 32084217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic E6 and/or E7 proteins drive proliferation and invasion of human papilloma virus‑positive head and neck squamous cell cancer through upregulation of Ror2 expression.
    Avincsal MO; Kamizaki K; Jimbo N; Shinomiya H; Nibu KI; Nishita M; Minami Y
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV
    Brand TM; Hartmann S; Bhola NE; Peyser ND; Li H; Zeng Y; Isaacson Wechsler E; Ranall MV; Bandyopadhyay S; Duvvuri U; LaVallee TM; Jordan RCK; Johnson DE; Grandis JR
    Clin Cancer Res; 2017 Jun; 23(12):3072-3083. PubMed ID: 27986750
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain-Derived Neurotrophin and TrkB in Head and Neck Squamous Cell Carcinoma.
    Dudás J; Riml A; Tuertscher R; Pritz C; Steinbichler TB; Schartinger VH; Sprung S; Glueckert R; Schrott-Fischer A; Johnson Chacko L; Riechelmann H
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.
    Tanaka N; Patel AA; Wang J; Frederick MJ; Kalu NN; Zhao M; Fitzgerald AL; Xie TX; Silver NL; Caulin C; Zhou G; Skinner HD; Johnson FM; Myers JN; Osman AA
    Clin Cancer Res; 2015 Nov; 21(21):4831-44. PubMed ID: 26124202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
    Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
    Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).
    Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
    Mol Cell Biochem; 2018 Nov; 448(1-2):321-333. PubMed ID: 29455435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.